Vontobel Holding Ltd. bought a new position in shares of Tempus AI, Inc. (NASDAQ:TEM - Free Report) during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 4,684 shares of the company's stock, valued at approximately $226,000.
Other institutional investors also recently bought and sold shares of the company. Operose Advisors LLC purchased a new stake in Tempus AI during the 4th quarter worth about $25,000. Cherry Tree Wealth Management LLC purchased a new stake in Tempus AI in the 1st quarter worth approximately $31,000. Farther Finance Advisors LLC acquired a new position in Tempus AI in the 4th quarter valued at $34,000. Prestige Wealth Management Group LLC lifted its stake in shares of Tempus AI by 910.4% during the 4th quarter. Prestige Wealth Management Group LLC now owns 1,071 shares of the company's stock worth $36,000 after purchasing an additional 965 shares during the period. Finally, Continuum Advisory LLC acquired a new stake in shares of Tempus AI during the first quarter worth $39,000. 24.22% of the stock is currently owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
Several equities analysts recently weighed in on the company. Needham & Company LLC reiterated a "buy" rating and set a $70.00 target price on shares of Tempus AI in a research report on Wednesday, May 7th. Guggenheim increased their price objective on shares of Tempus AI from $65.00 to $75.00 and gave the stock a "buy" rating in a report on Monday, June 30th. Morgan Stanley raised their target price on shares of Tempus AI from $60.00 to $65.00 and gave the stock an "overweight" rating in a research report on Friday, May 9th. Bank of America upped their price target on shares of Tempus AI from $68.00 to $70.00 and gave the stock a "neutral" rating in a research report on Wednesday, June 25th. Finally, BTIG Research began coverage on shares of Tempus AI in a research note on Monday, April 21st. They set a "buy" rating and a $60.00 price target on the stock. Six research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company's stock. Based on data from MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus target price of $65.09.
Check Out Our Latest Research Report on Tempus AI
Insider Activity
In related news, EVP Erik Phelps sold 51,317 shares of Tempus AI stock in a transaction on Monday, June 16th. The shares were sold at an average price of $72.56, for a total value of $3,723,561.52. Following the completion of the sale, the executive vice president owned 97,779 shares in the company, valued at approximately $7,094,844.24. The trade was a 34.42% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, COO Ryan Fukushima sold 5,000 shares of the business's stock in a transaction dated Monday, July 7th. The stock was sold at an average price of $60.00, for a total transaction of $300,000.00. Following the completion of the sale, the chief operating officer directly owned 145,000 shares of the company's stock, valued at $8,700,000. The trade was a 3.33% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 612,522 shares of company stock worth $41,600,238 over the last quarter. Corporate insiders own 27.60% of the company's stock.
Tempus AI Stock Up 2.0%
Tempus AI stock traded up $1.19 during midday trading on Thursday, hitting $59.60. 8,302,801 shares of the company were exchanged, compared to its average volume of 7,495,063. The company has a market cap of $10.32 billion and a PE ratio of -7.64. The company's fifty day moving average price is $62.98 and its 200-day moving average price is $54.65. Tempus AI, Inc. has a fifty-two week low of $31.36 and a fifty-two week high of $91.45. The company has a debt-to-equity ratio of 2.45, a current ratio of 1.71 and a quick ratio of 1.56.
Tempus AI (NASDAQ:TEM - Get Free Report) last issued its quarterly earnings data on Tuesday, May 6th. The company reported ($0.24) EPS for the quarter, topping analysts' consensus estimates of ($0.27) by $0.03. The firm had revenue of $255.74 million for the quarter, compared to analyst estimates of $248.13 million. Tempus AI had a negative net margin of 88.27% and a negative return on equity of 533.21%. The company's quarterly revenue was up 75.4% compared to the same quarter last year. On average, research analysts predict that Tempus AI, Inc. will post -6.15 EPS for the current fiscal year.
About Tempus AI
(
Free Report)
Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.
Recommended Stories
Before you consider Tempus AI, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tempus AI wasn't on the list.
While Tempus AI currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
